Open original FDA record ↗Recall record
- FDA identifier
- Z-2159-2019
- Company in FDA record
- DRG Instruments GmbH
- FDA record creation date
- Aug 5, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Salivary assay may observe a higher percentage of samples with 0 pg/ml testosterone or results which are too low. Saliva samples in the low measuring range of the kit(< 50 pg/ml) were assayed significantly lower
Source facts
- Action
- DRG International issued notification via email on 5/21/19 advising of the problem, health risk and action to take: 1. We kindly ask you to immediately examine your stock and promptly quarantine these products, 2. Please send back or discard all unused kits. 3. Please use the attached response form, fill, sign and send back to us.4. Please inform your customers and forward this letter and notice to persons who received the affected lots and request they fill out the form and return at once.5. Patient samples that have been determined with the affected lots should be checked again carefully. If results are lower than expected samples should be re-run again. 6. Please tell us if you have experienced any problem with this lot and specify the details. Reply to DRG (email: qa@drg-international.com and copy drqsupport@drginternational.com).
- Initiated
- 2019-05-21
- Root cause
- Under Investigation by firm
- Terminated
- 2020-05-29
- Distribution
- Worldwide Distribution - US Nationwide CA, MI Foreign: Canada, Brazil, China, Poland
- Recall number
- Z-2159-2019
- Recall status
- Terminated
- CDRH record ID
- 173940
- FDA record created
- 2019-08-05
- Recall event number
- 83183